The current price of EBS is $5.85 — it has decreased by 0.85% since the previous close. Data as of Nov 5, 2026.
EBS is down 17.72% over the past week, down 19.20% over the past month and down 43.42% over the past year. The price is below its 200-day moving average of $7.94.
Analysts' average 12-month price target for EBS is $10.00, which implies 70.94% upside from the current price. Individual estimates range from $10.00 to $10.00.
Of the 3 analysts covering Emergent BioSolutions Inc., 2 rate it a buy and 1 rates it a strong sell. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Emergent BioSolutions Inc. has a market capitalization of $299.95M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Emergent BioSolutions Inc. posted a loss of $0.36 per share against an estimate of -$0.3914, beating expectations by 8.03%. Upcoming reports are listed in the earnings calendar.
Emergent BioSolutions Inc. reported revenue of $110M in its most recent quarter, which has decreased by 52.40% compared with the same quarter a year earlier. Analysts had expected $123.22M.
Emergent BioSolutions Inc. has not paid any dividends over the past year.
Companies most comparable to Emergent BioSolutions Inc. include COMPASS Pathways plc, Rigel Pharmaceuticals, Inc., Corvus Pharmaceuticals, Inc., Esperion Therapeutics, Inc. and Olema Pharmaceuticals, Inc.
In the latest trading session EBS moved between $5.80 and $6.04, a range of 4.13% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Emergent BioSolutions Inc. shows a strong sell rating today and a sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Emergent BioSolutions Inc. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks EBS has traded between $4.36 and $14.06. The current price is 58.39% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.